D01.3

Clinical Causes: Persistent infection with high-risk human papillomavirus (HPV), especially types 16 and 18 Immunocompromised states, such as HIV infection or post-transplantation immunosuppression Chronic anal irritation or inflammation History of anal or rectal sexually transmitted infections Multiple sexual partners or unprotected anal intercourse Smoking, which may impair immune response and promote abnormal cell changes

Key Symptoms: Often no noticeable symptoms in early stages Itching or irritation in the anal area Discomfort or pain during bowel movements Bleeding from the anus, either seen on toilet paper or in stool Visible patches or lesions in the anal canal during examination Sensation of a mass or abnormal growth in the anal region

Diagnosis Path: Diagnosis typically involves a combination of physical examinations and diagnostic procedures, including: - **Digital rectal exam** to assess abnormalities - **Anal Pap smear** (anal cytology) to detect abnormal cells - **High-resolution anoscopy** to visualize and biopsy suspicious areas - **Biopsy of abnormal tissue** to confirm the presence of carcinoma in situ and differentiate it from other benign conditions Laboratory tests, including HPV testing, may also be performed to identify viral infections associated with cellular changes.

Treatment Protocols: Treating carcinoma in situ of the anal canal aims to remove or destroy abnormal cell growth and prevent progression to invasive cancer. Common approaches include: - **Topical treatments**, such as 5-fluorouracil or imiquimod creams, to target abnormal cells - **Cryotherapy**, which involves freezing the affected tissue - **Laser therapy** to vaporize abnormal tissue - **Surgical excision** in cases where lesions are extensive or unresponsive to other treatments - **Regular follow-up** with anal examinations and repeat biopsies to monitor for recurrence or progression Management plans are tailored to individual patient circumstances, including overall health and the extent of the condition.